#AAPP2026 Spotlight: Repurposing GLP-1 Receptor Agonists for Substance Use Disorders, presented by Stephanie Weiss, MD, PhD.
GLP-1 receptor agonists, traditionally used for metabolic conditions, are gaining attention for their potential to modulate reward pathways in addiction. This presentation explores the neurobiological rationale and emerging clinical evidence supporting their use in alcohol and other substance use disorders. Join us at the 2026 AAPP Annual Meeting in Bellevue, WA, on Seattle’s Eastside, for this session!
#AAPP #psychpharmacy #acpe #bcpp #bcpmp